Atlas Trials

A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Clinical trial NCT02012920 · COMPLETED

Trial details

NCT number
NCT02012920
Sponsor
Innocrin Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Castration-resistant Prostate CancerCRPC
Start date
2011-12-01
Primary completion
2018-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.